TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
11,648
|
12,784
|
10,854 |
| Financial expenses |
162
|
38
|
40 |
| Earnings before taxes |
-2,274
|
-1
|
1,324 |
| EBITDA |
-1,299
|
1,173
|
2,249 |
| Total assets |
18,700
|
16,997
|
15,785 |
| Current assets |
6,381
|
7,158
|
7,276 |
| Current liabilities |
6,394
|
3,602
|
2,888 |
| Equity capital |
12,158
|
9,700
|
10,183 |
| - share capital |
13
|
15
|
15 |
| Employees (average) |
75
|
66
|
56 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
65.0%
|
57.1%
|
64.5% |
| Turnover per employee |
155
|
194
|
194 |
| Profit as a percentage of turnover |
-19.5%
|
0.0%
|
12.2% |
| Return on assets (ROA) |
-11.3%
|
0.2%
|
8.6% |
| Current ratio |
99.8%
|
198.7%
|
251.9% |
| Return on equity (ROE) |
-18.7%
|
0.0%
|
13.0% |
| Change turnover | |||
| Change turnover % | 20% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % | 18% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.